19 May 2013
Keywords: simcere, make, sell, cheap, relenza, uk, drug
Article | 09 October 2006
UK drug major GlaxoSmithKline has signed a licensing agreement with Simcere Pharmaceutical Group granting the Nanjing, China-based firm the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 2006
17 May 2013
© 2013 thepharmaletter.com